466 results
Repair and replace: latest insights in transcatheter treatment of mitral and tricuspid regurgitation
20 May 2025 – From EuroPCR 2025
Join Michael Mullen, Federico De Marco, and Philipp Lurz as they discuss the latest breakthroughs in the treatment of mitral and tricuspid regurgitation at EuroPCR 2025. In this roundtable session, they delve into both repair and replacement techniques, offering insights into new systems and their impact...
Tricuspid TEER: learnings from the 2-year outcomes of TRILUMINATE Pivotal trial & bRIGHT study
20 May 2025 – From EuroPCR 2025
At EuroPCR 2025, Marianna Adamo and Ralph Stephan von Bardeleben discussed the latest findings on tricuspid valve repair using transcatheter edge-to-edge repair (TEER).
The 2-year results from the TRILUMINATE Pivotal trial showed a significant reduction in tricuspid regurgitation, lasting improvements in quality of life, and a notable...
Tricuspid regurgitation and heart failure with preserved ejection fraction
11 Jun 2025
Watch the replay of this webinar with M. Adamo, M. Metra, K-P. Kresoja, P. Lurz, P. Ponikowski and M. Sitges and learn about mechanisms and risk factors for HFpEF and TR, and so much more!
Structural and Valvular Interventions: EuroPCR 2025 highlights
22 May 2025 – From EuroPCR 2025
Christopher Cook, Nicolas Dumonteil, and Bernard Prendergast share their top EuroPCR 2025 highlights in structural heart interventions. Challenging cases like re-do TAVI, coronary re-access difficulties, and leaflet modification took center stage in case-based and LIVE sessions. Cutting-edge research was featured too, including a meta-analysis combining the...
Tricuspid hotline: new devices
22 May 2025 – From EuroPCR 2025
Discover cutting-edge developments in transcatheter tricuspid valve replacement with new device technologies. Review first-in-human trials, early outcomes from multicenter studies, and innovative designs that promise to advance tricuspid regurgitation treatment.
Predictors outcome after tricuspid TEER: is there a perfect tool
22 May 2025 – From EuroPCR 2025
Examine predictors of outcome following tricuspid transcatheter edge-to-edge repair (TEER) in this focused session. Review meta-analyses on TEER efficacy, survival benefits in high-risk patients from the EuroTR registry, and prognostic value of MELD?XI score from the TRISPA registry. Learn about TRI.Fr eligibility criteria and validation of...
Assessment and management of patients with multivalvular disease involving the tricuspid valve
22 May 2025 – From EuroPCR 2025
Gain expertise on managing multivalvular disease involving the tricuspid valve by understanding diagnostic challenges, intervention indications, and associated pathophysiological factors. This session includes complex case studies focusing on combined valvular lesions and guideline limitations.
Optimising TEER in challenging anatomies
22 May 2025 – From EuroPCR 2025
Optimize transcatheter edge-to-edge repair (TEER) strategies in challenging anatomies with focus on tricuspid valve interventions, recognition of multivalvular disease, and planning combined mitral and tricuspid TEER procedures. Case studies highlight feasibility challenges and dual valve repair approaches.
Challenging tricuspid TEER cases
22 May 2025 – From EuroPCR 2025
Explore challenging tricuspid transcatheter edge-to-edge repair (TEER) cases highlighting combined LAA occlusion and mitral valve repair, anatomical complexities, and strategies to complete surgical interventions percutaneously. Discuss the balance between procedural perfection and clinical practicality in complex valve anatomies.
The many faces of TTVR
21 May 2025 – From EuroPCR 2025
Discover the diverse clinical scenarios of transcatheter tricuspid valve replacement (TTVR). This session presents complex cases including acute right ventricular afterload mismatch, combined pulmonary and tricuspid valve interventions in carcinoid heart disease, and challenges in dilated cava anatomy, showcasing the expanding frontiers of TTVR therapy.
